english.ahram.org.eg
Neuropsychiatric symptoms persist in COVID-19 survivors
Neuropsychiatric symptoms are common in COVID-19 survivors, a large new analysis confirms
Reuters , Sunday 9 May 2021

Tweet
Neuropsychiatric symptoms are common in COVID-19 survivors, a large new analysis confirms.
Researchers pooled data from 51 studies involving a total of nearly 19,000 patients who were tracked for up to six months.
The average follow-up was 77 days post-diagnosis. Overall, 27.4% reported sleep problems, 24.4% had fatigue, 20.2% scored poorly on objective tests of cognition, 19.1% reported anxiety, and 15.7% had post-traumatic stress.
Nerve disturbances and dizziness or vertigo were less common but were seen in "a non-negligible proportion" of patients, the research team reported on  in a paper posted on medRxiv ahead of peer review.
Only about 7% of the patients were said to have required intensive care, based on this meta-analysis in which some papers were not clear on intensive care figures. "There was little or no evidence of differential symptom prevalence based on hospitalization status, severity, or follow-up duration," the researchers said.
They caution that some of the patients may still have been in the acute phase of their infections, and longer follow-up will be necessary to know how long these problems persist, and whether they are effects of viral infection in general or are specific to the new coronavirus. 
Search Keywords:
Neuropsychiatric symptoms-
COVID-19-
Short link:
 
Recommended by
Latest
09:49 Armenia PM party wins snap parliamentary election
23:02 Lackluster Pyramids FC held to 0-0 draw by Raja in Confed Cup semis
21:46 Mali ex-rebels question junta's commitment to 2015 peace deal
21:03 Yemeni officials say battle for key city intensifies
21:01 Centre-right leads French regional vote, ahead of far-right: Early results
20:36 Shaqiri scores twice as Switzerland beats Turkey at Euro 2020
20:32 Italy's reserves beat Wales 1-0 at Euro 2020
20:19 Norway decides against Qatar World Cup boycott
20:06 Iran's sole nuclear power plant undergoes emergency shutdown
19:57 EU diplomat: mistrust at core of Lebanon political crisis
19:31 Myanmar junta leader departs for Moscow security conference: state media
18:49 Griezmann defends Benzema as France attack struggles to fire
18:47 Nine children among 10 killed in Alabama crash: Coroner
18:46 Renowned Egyptian film producer and director Hany Guirguis Fawzy dies
18:41 CAF considers creating 'African Super League' despite European failure
18:27 Zamalek defender Mahmoud Hamdi signs four-year contract extension
18:23 England's Trippier backs misfiring Kane to silence critics
18:04 Afghan President Ghani to visit Washington on Friday: White House
17:55 Netanyahu to leave prime minister's residence by July 10
17:54 US says preparing new Russia sanctions over Navalny poisoning
17:53 Iran's supreme leader still arbiter of nuclear deal: US advisor
17:49 Talks 'closer' to saving Iran nuclear deal: EU envoy
16:56 Russia's ambassador heads back to US after recall
16:44 Diplomats meet in Vienna for more Iran nuclear talks
16:36 Libya's interim government reopens Mediterranean highway
16:32 Israeli PM: World powers must 'wake up' on Iran nuke deal
15:19 Barcelona move will give Depay 'something extra', says Dutch coach De Boer
14:51 French-Armenian film Storgetnya among short documentaries discussed in Ismailia
14:50 Israel orders inquiry into Mount Meron deadly stampede
14:26 Toothless Spain battling for Euro 2020 lives after Poland stalemate
Readers Picks
Most Viewed
1. French-Armenian film Storgetnya among short documentaries discussed in Ismailia
2. Four decades on, where's the HIV vaccine?
3. Renowned Egyptian film producer and director Hany Guirguis Fawzy dies
4. Seeking a pill to cure Covid: drugmakers eye alternative to vaccines
Ahram online
© 2010 Ahram Online.
Find us on Google+Find us on facebookFind us on twitter
HomeEgyptBusinessOpinionWorldArts & CultureSportsLife & StyleHeritageBooksAnalysisFolkMultimedia